Focused On Life

Developing novel therapies for serious diseases

Learn More
Focused On Life Developing novel therapies for serious diseases
Driven By Science Rapid, efficient, cost-effective approach
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families.

Medivation is proud to be a 2015 Top Workplace Learn More
Top Workplaces 2013, 2014, and 2015 Bay Area News Group








Latest News

August 24, 2015
Medivation to Expand Global Oncology Franchise With the Acquisition of All Worldwide Rights to Talazoparib (BMN 673), a Potent PARP Inhibitor, From BioMarin Learn More